INVO Fertility Files Proxy Statement

Ticker: IVF · Form: DEFA14A · Filed: Dec 30, 2025 · CIK: 1417926

Sentiment: neutral

Topics: proxy-statement, corporate-governance, name-change

TL;DR

INVO Fertility (formerly NAYA) filed its proxy statement, no fee paid.

AI Summary

INVO Fertility, Inc. (formerly NAYA Biosciences, Inc.) filed a DEFA14A proxy statement on December 30, 2025. The filing indicates no fee was required for this submission. The company, previously known as INVO Bioscience, Inc., is incorporated in Nevada and operates in the Surgical & Medical Instruments & Apparatus industry.

Why It Matters

Proxy statements are crucial for shareholders as they detail important company information, including proposals to be voted on at shareholder meetings, executive compensation, and other governance matters.

Risk Assessment

Risk Level: low — This filing is a routine proxy statement and does not contain information that inherently suggests significant new risks for investors.

Key Players & Entities

FAQ

What is the purpose of this DEFA14A filing?

This DEFA14A filing is a proxy statement filed by INVO Fertility, Inc. pursuant to Section 14(a) of the Securities Exchange Act of 1934.

When was this filing made?

The filing was made on December 30, 2025.

What is the company's current name?

The company's current name is INVO Fertility, Inc.

What were some of the company's previous names?

The company was formerly known as NAYA Biosciences, Inc. and INVO Bioscience, Inc.

Was there a filing fee associated with this document?

No fee was required for this filing.

Filing Stats: 125 words · 1 min read · ~1 pages · Grade level 12.4 · Accepted 2025-12-30 14:01:56

Filing Documents

From the Filing

UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant  Filed by a Party other than the Registrant  Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to §240.14a-12 INVO FERTILITY, INC. (Name of Registrant as Specified in Its Charter) (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 2(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

View Full Filing

View this DEFA14A filing on SEC EDGAR

View on Read The Filing